Literature DB >> 15116311

Age-associated decline in resistance to Babesia microti is genetically determined.

Edouard Vannier1, Ingo Borggraefe, Samuel R Telford, Sanjay Menon, Timothy Brauns, Andrew Spielman, Jeffrey A Gelfand, Henry H Wortis.   

Abstract

BACKGROUND: Although infection by the protozoan Babesia microti is rarely symptomatic in immunocompetent young people, healthy individuals aged >50 years may experience life-threatening disease. To determine the basis for this age relationship, we developed a mouse model of babesiosis using a novel clinical isolate of B. microti.
METHODS: Mice were infected at 2, 6, 12, or 18 months. Parasitemia was monitored on Giemsa-stained blood smears or by flow cytometry.
RESULTS: In DBA/2 mice, early and persistent parasitemias increased with age at infection. BALB/c and C57BL/6 mice were resistant, regardless of age, which indicates that allelic variation determines resistance to B. microti. Unlike immunocompetent mice, SCID mice, which retain an innate immune system but lack the lymphocytes needed for adaptive immunity, developed high and persistent levels of parasitemia that were markedly reduced by transfer of naive BALB/c or DBA/2 splenocytes. BALB/c cells reduced the persistent parasitemia to a greater extent than did age-matched DBA/2 cells. Of importance, there was an age-associated loss of protection by cells of both strains.
CONCLUSION: The resistance to B. microti infection conferred by the adaptive immune system is genetically determined and associated with age. We postulate that there are age-related differences in the expression of alleles critical for adaptive immunity to B. microti.

Entities:  

Mesh:

Year:  2004        PMID: 15116311     DOI: 10.1086/382965

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

Review 1.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

2.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

Review 3.  Babesiosis.

Authors:  Edouard G Vannier; Maria A Diuk-Wasser; Choukri Ben Mamoun; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 4.  Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan.

Authors:  William R Swindell
Journal:  Ageing Res Rev       Date:  2011-12-23       Impact factor: 10.895

Review 5.  Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.

Authors:  David A Leiby
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Babesia microti primarily invades mature erythrocytes in mice.

Authors:  Ingo Borggraefe; Jie Yuan; Sam R Telford; Sanjay Menon; Rouette Hunter; Sohela Shah; Andrew Spielman; Jeffrey A Gelfand; Henry H Wortis; Edouard Vannier
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

Authors:  Neeharik Mareedu; Anna M Schotthoefer; Jason Tompkins; Matthew C Hall; Thomas R Fritsche; Holly M Frost
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 8.  Caloric restriction and the aging process: a critique.

Authors:  Rajindar S Sohal; Michael J Forster
Journal:  Free Radic Biol Med       Date:  2014-06-02       Impact factor: 7.376

9.  Insulator-based dielectrophoretic diagnostic tool for babesiosis.

Authors:  Ezekiel O Adekanmbi; Massaro W Ueti; Brady Rinaldi; Carlos E Suarez; Soumya K Srivastava
Journal:  Biomicrofluidics       Date:  2016-06-17       Impact factor: 2.800

Review 10.  Human babesiosis.

Authors:  Edouard Vannier; Benjamin E Gewurz; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.